Genistein (NPI 031L) is a naturally occurring soy isoflavone, a multi-targeted tyrosine kinase inhibitor. Genistein has antitumor, antioxidant, and anthelmintic properties, and also produces estrogen-like effects in the body.

HeLa cells:35 µM, MCF-7 cells:10 μM, SW620 cells:152.60 ± 19.13 µM, CaSki cells:24 µM, MDA-MB-231 cells:10 μM, ME-180 cells:60 µM, HaCaT cells:225.01 ± 7.06 µM, MRGPRX2:38.3 μM (EC50), HBL-100 cells:10 μM, SW480 cells:128.80 ± 15.87 μM, EGFR:0.6 μM (EC50), Topoisomerase II:25-80 µm (EC50)

METHODS: Breast cancer cells MCF-7 were treated with Genistein (10-200 µM) for 24-48 h. Cell viability was measured by MTT assay.
RESULTS: Genistein was cytotoxic to MCF-7 cells treated with Genistein at a concentration of more than 80 µM for 24 hours. Treatment with Genistein above 50 µM for 48 h induced cytotoxicity in MCF-7 cells. [1]
METHODS: MCF-7 cells or differentiating 3T3-L1 cells were treated with Genistein (50-200 µM) for 24-72 h, and the expression levels of target proteins were detected by Western Blot.
RESULTS: In MCF-7 cells, all concentrations of Genistein down-regulated ERα expression; furthermore, the effect of Genistein was greater after 48 and 72 h. Compared with the negative control (3T3-L1 preadipocytes), the expression of ERα was upregulated 1.98-fold in 3T3-L1 cells after 48 h of Genistein treatment to initiate differentiation. [2]

METHODS: To assay antitumor activity in vivo, Genistein (2-20 mg/kg in 25 mmol/L Na2CO3) was administered by gavage to B6C3F1 mice bearing B16F10 tumors once daily for 28 days.
RESULTS: Consistent with the chemopreventive effects of Genistein, exposure to this compound significantly increased host resistance to B16F10 tumors, which was reflected in a reduction in the number of lung tumor nodules after tumor cell injections at moderate to high dose levels. [3]

Purified FXa is obtained after activation with Russell's viper venom followed by affinity chromatography. The resulting FXa is > 95% pure as judged by sodium dodecylsulfate polyacrylamide gel electrophoresis. The substrate affinity values for FXa, expressed as the Michaelis-Menten-Henri constant (Km), for human, rabbit, rat and dog FXa are determined using the chromogenic substrate S-2765, and are 36, 60, 240 and 70 μM, respectively. The substrate hydrolysis is monitored by measuring absorbance at 405 nm at 25°C for up to 30 min using a SpectraMax 384 Plus plate reader and SoftMax. FXa activity for each substrate and inhibitor concentration pair is determined in duplicate. The Ki values are calculated by non-linear least-squares fitting of the steady-state substrate hydrolysis rates to the equation for competitive inhibition (Equation 1) using GRAFIT, where v equals reactions velocity in OD min?1, Vmax equals maxiumum reaction velocity, S equals substrate concentration, and I equals inhibitor concentration.

Genistein is dissolved in DMSO and stored, and then diluted with appropriate medium before use[1]. The IC50 values for Genistein are determined by the MTT assay. Briefly, the MTT assay is a colorimetric assay that is based on the ability of living but not dead cells to reduce a tetrazolium-based compound to a blue formazan product. The formazan crystals are solubilized in DMSO, and the absorbance is measured at 540 nm. The absorbance at 540 nm is proportional to the number of viable cells. The lC50 values obtained with the MTT assay are compared with the lC50 values obtained by counting viable cells using trypan blue dye exclusion and by tritiated thymidine incorporation into DNA[1].

DMSO: 262.5 mg/mL (971.36 mM), Sonication is recommended.

H2O: < 1 mg/mL (insoluble or slightly soluble)

Ethanol: 2 mg/mL (7.4 mM), Sonication is recommended.

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5.4 mg/mL (19.98 mM), Solution.